InvestorsHub Logo
Followers 835
Posts 120298
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 77

Monday, 08/07/2017 6:06:16 PM

Monday, August 07, 2017 6:06:16 PM

Post# of 182
CHRS now hopes to submit Humira FoB applications to both FDA and EMA in 2H18 (later than previously announced), using one of multiple formulations CHRS is still developing to work around ABBV’s formulation patents.

CHRS has found a new fill/finish CMO to handle product for both the FDA and EMA applications, addressing the issue disclosed in June (#msg-132511112).

Source: Today’s 2Q17 CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CHRS News